NCT04322461View on ClinicalTrials.gov

Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 27, 2024

Study Completion Date

May 27, 2024

Conditions
Parkinson DiseaseAlzheimer Disease
Interventions
DIETARY_SUPPLEMENT

Betaquik MCT supplement

50g/day divided in 3. Breakfast, lunch and dinner

Trial Locations (1)

J1H 4C4

Centre de recherche sur le vieillissement, Sherbrooke

All Listed Sponsors
collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

lead

Université de Sherbrooke

OTHER